Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 3

Sponsor Class

OTHER 128INDUSTRY 98NIH 13NETWORK 11OTHER_GOV 5UNKNOWN 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 3

Interventions

Paclitaxel 7Epirubicin 7Capecitabine 7pyrotinib 5Docetaxel 5Carboplatin 5Vinorelbine 4Fulvestrant 4Cyclophosphamide 4exemestane 3anlotinib 3Radiotherapy 3Radiation Dose Hypofractionation 3Etoposide 3pirarubicin 2palbociclib 2apatinib 2Standard of Care 2Neoadjuvant Therapy 2Letrozole 2Albumin-Bound Paclitaxel 2toripalimab 1titanium silicide 1nimotuzumab 1neratinib 1lobaplatin 1liposomal doxorubicin 1icaritin 1eribulin 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
UNKNOWN × exemestane × Breast × Clear all
NCT02765373 2019-05-13

Effects of Adjuvant Endocrine Therapy With Aromatase Inhibitors on the Postoperative Lipid Levels in Postmenopausal Breast Cancer Patients

ChineseAMS

Unknown
500 enrolled
Breast

Breast Neoplasms

NCT02646735 2017-01-02

FRIEND

ChineseAMS

Phase 2 Unknown
148 enrolled
Breast

Breast Neoplasms

NCT01431053 2013-03-13

Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer

ChineseAMS

Phase 2 Unknown
160 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡